Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


03.09.2018

1 Ann Neurol
3 J Neural Transm (Vienna)
1 J Neurochem
15 Mov Disord
1 Nature
1 Neurobiol Dis
1 Neurology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. PIHLSTROM L, Blauwendraat C, Cappelletti C, Berge-Seidl V, et al
    A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.
    Ann Neurol. 2018 Aug 26. doi: 10.1002/ana.25274.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  2. FRUNDT O, Mainka T, Schonwald B, Muller B, et al
    The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care.
    J Neural Transm (Vienna). 2018 Aug 22. pii: 10.1007/s00702-018-1918.
    PubMed     Text format     Abstract available

  3. MURAKAMI H, Yamamoto K, Yasumoto T, Kimura A, et al
    Cerebrospinal fluid 5-HIAA concentrations correlate with cardiac uptake of (123)I-MIBG during myocardial scintigraphy in drug naive Parkinson's disease.
    J Neural Transm (Vienna). 2018 Aug 23. pii: 10.1007/s00702-018-1917.
    PubMed     Text format     Abstract available

  4. COVA I, Priori A
    Diagnostic biomarkers for Parkinson's disease at a glance: where are we?
    J Neural Transm (Vienna). 2018 Aug 25. pii: 10.1007/s00702-018-1910.
    PubMed     Text format     Abstract available


    J Neurochem

  5. KOMNIG D, Dagli CT, Habib P, Zeyen T, et al
    Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson disease and does not lead to a sustainable increase of brain BDNF.
    J Neurochem. 2018 Aug 28. doi: 10.1111/jnc.14575.
    PubMed     Text format     Abstract available


    Mov Disord

  6. ROZANI V, Gurevich T, Giladi N, El-Ad B, et al
    Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study.
    Mov Disord. 2018 Aug 25. doi: 10.1002/mds.27413.
    PubMed     Text format     Abstract available

  7. MESTRE TA, Shamy M, Benedetti F, Lang AE, et al
    Harnessing the power of placebos in movement disorders: Insights from Parkinson's disease in clinical research and practice.
    Mov Disord. 2018 Aug 25. doi: 10.1002/mds.27409.
    PubMed     Text format     Abstract available

  8. SIEURIN J, Andel R, Tillander A, Valdes EG, et al
    Occupational stress and risk for Parkinson's disease: A nationwide cohort study.
    Mov Disord. 2018 Aug 25. doi: 10.1002/mds.27439.
    PubMed     Text format     Abstract available

  9. DEFFAINS M, Iskhakova L, Katabi S, Israel Z, et al
    Longer beta oscillatory episodes reliably identify pathological subthalamic activity in Parkinsonism.
    Mov Disord. 2018 Aug 25. doi: 10.1002/mds.27418.
    PubMed     Text format     Abstract available

  10. WANNEVEICH M, Moisan F, Jacqmin-Gadda H, Elbaz A, et al
    Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010-2030) in France.
    Mov Disord. 2018 Aug 25. doi: 10.1002/mds.27447.
    PubMed     Text format     Abstract available

  11. POSTUMA RB, Poewe W, Litvan I, Lewis S, et al
    Validation of the MDS clinical diagnostic criteria for Parkinson's disease.
    Mov Disord. 2018 Aug 25. doi: 10.1002/mds.27362.
    PubMed     Text format     Abstract available

  12. BERG D, Adler CH, Bloem BR, Chan P, et al
    Movement disorder society criteria for clinically established early Parkinson's disease.
    Mov Disord. 2018 Aug 25. doi: 10.1002/mds.27431.
    PubMed     Text format     Abstract available

  13. EHGOETZ MARTENS KA, Shine JM, Walton CC, Georgiades MJ, et al
    Evidence for subtypes of freezing of gait in Parkinson's disease.
    Mov Disord. 2018;33:1174-1178.
    PubMed     Text format     Abstract available

  14. RAKOVIC A, Domingo A, Grutz K, Kulikovskaja L, et al
    Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism.
    Mov Disord. 2018;33:1108-1118.
    PubMed     Text format     Abstract available

  15. INOUE KI, Miyachi S, Nishi K, Okado H, et al
    Recruitment of calbindin into nigral dopamine neurons protects against MPTP-Induced parkinsonism.
    Mov Disord. 2018 Aug 30. doi: 10.1002.
    PubMed     Text format     Abstract available

  16. GUPTA DK, Fahn S, Tatsuoka C, Kang UJ, et al
    Hoehn and Yahr stage 3 and postural stability item in the movement disorder society-unified Parkinson's disease rating scale.
    Mov Disord. 2018;33:1188-1189.
    PubMed     Text format    

  17. LOESCH DZ, Tassone F, Mellick GD, Horne M, et al
    Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females.
    Mov Disord. 2018;33:1178-1181.
    PubMed     Text format     Abstract available

  18. REYES CJ, Westenberger A
    An integrated OMICS approach unravels the elusive genetic cause of X-linked dystonia-parkinsonism.
    Mov Disord. 2018;33:1095.
    PubMed     Text format    

  19. SANTENS P, De Letter M, Lees AJ, Krack P, et al
    Crime and Parkinson's: The jury is out.
    Mov Disord. 2018;33:1092-1094.
    PubMed     Text format    

  20. SKORVANEK M, Martinez-Martin P, Stebbins GT, Goetz CG, et al
    Reply: Hoehn and Yahr stage 3 and Postural stability item in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
    Mov Disord. 2018;33:1189-1190.
    PubMed     Text format    


    Nature

  21. ABBOTT A
    Is 'friendly fire' in the brain provoking Alzheimer's disease?
    Nature. 2018;556:426-428.
    PubMed     Text format    


    Neurobiol Dis

  22. MOLONEY EB, Moskites A, Ferrari EJ, Isacson O, et al
    The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress.
    Neurobiol Dis. 2018 Aug 24. pii: S0969-9961(18)30484.
    PubMed     Text format     Abstract available


    Neurology

  23. SPERLING SA, Shah BB, Barrett MJ, Bond AE, et al
    Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life.
    Neurology. 2018 Aug 29. pii: WNL.0000000000006279.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: